The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB

Childhood tuberculosis (TB) has hitherto been treated through estimation of pediatric doses through the crushing of adult pills, but the bitter taste of the pills and the inaccuracy of this dosing method presents a challenge for both patients and healthcare providers, leading to poor treatment outco...

Full description

Bibliographic Details
Main Authors: Lena Faust, Kawsar Abdi, Kristin Davis, Chen He, Caitlin Mehrotra, Emilie Stibolt
Format: Article
Language:English
Published: Springer 2019-08-01
Series:Journal of Epidemiology and Global Health
Subjects:
Online Access:https://www.atlantis-press.com/article/125917033/view
_version_ 1828278161725456384
author Lena Faust
Kawsar Abdi
Kristin Davis
Chen He
Caitlin Mehrotra
Emilie Stibolt
author_facet Lena Faust
Kawsar Abdi
Kristin Davis
Chen He
Caitlin Mehrotra
Emilie Stibolt
author_sort Lena Faust
collection DOAJ
description Childhood tuberculosis (TB) has hitherto been treated through estimation of pediatric doses through the crushing of adult pills, but the bitter taste of the pills and the inaccuracy of this dosing method presents a challenge for both patients and healthcare providers, leading to poor treatment outcomes. The TB Alliance therefore launched the Speeding Treatments to End Pediatric-Tuberculosis (STEP-TB) project to incentivize the introduction of pediatric Fixed-Dose Combinations (FDCs) of TB drugs. This case study describes the elements of this project, evaluates its impact, and highlights future challenges for pediatric TB treatment. The impact assessment incorporates both market impact as well as projected public health impact, evaluating the availability, affordability, and quality of the FDCs, and lastly providing a projection of lives saved as a result of scale-up of the FDCs to near-universal availability and utilization, based on a publicly available pediatric TB-specific model. STEP-TB resulted in the development of two child-friendly FDCs that were successfully brought to market and made available in 20 of the project’s 22 high-burden countries. On the basis of a country-specific projection of pediatric TB mortality in Kenya, scale-up to near-universal availability and utilization of the new FDCs could reduce pediatric TB-associated mortality by 2660 cases over the next 5 years. Future challenges include maintaining affordable prices for the FDCs and considering mechanisms to incentivize their introduction among high-risk groups in low-burden countries.
first_indexed 2024-04-13T07:26:12Z
format Article
id doaj.art-db0cd6e6f2d3421e8eebfa82f8c14429
institution Directory Open Access Journal
issn 2210-6014
language English
last_indexed 2024-04-13T07:26:12Z
publishDate 2019-08-01
publisher Springer
record_format Article
series Journal of Epidemiology and Global Health
spelling doaj.art-db0cd6e6f2d3421e8eebfa82f8c144292022-12-22T02:56:28ZengSpringerJournal of Epidemiology and Global Health2210-60142019-08-019310.2991/jegh.k.190812.001The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TBLena FaustKawsar AbdiKristin DavisChen HeCaitlin MehrotraEmilie StiboltChildhood tuberculosis (TB) has hitherto been treated through estimation of pediatric doses through the crushing of adult pills, but the bitter taste of the pills and the inaccuracy of this dosing method presents a challenge for both patients and healthcare providers, leading to poor treatment outcomes. The TB Alliance therefore launched the Speeding Treatments to End Pediatric-Tuberculosis (STEP-TB) project to incentivize the introduction of pediatric Fixed-Dose Combinations (FDCs) of TB drugs. This case study describes the elements of this project, evaluates its impact, and highlights future challenges for pediatric TB treatment. The impact assessment incorporates both market impact as well as projected public health impact, evaluating the availability, affordability, and quality of the FDCs, and lastly providing a projection of lives saved as a result of scale-up of the FDCs to near-universal availability and utilization, based on a publicly available pediatric TB-specific model. STEP-TB resulted in the development of two child-friendly FDCs that were successfully brought to market and made available in 20 of the project’s 22 high-burden countries. On the basis of a country-specific projection of pediatric TB mortality in Kenya, scale-up to near-universal availability and utilization of the new FDCs could reduce pediatric TB-associated mortality by 2660 cases over the next 5 years. Future challenges include maintaining affordable prices for the FDCs and considering mechanisms to incentivize their introduction among high-risk groups in low-burden countries.https://www.atlantis-press.com/article/125917033/viewPediatric tuberculosisfixed-dose combinationsimpact evaluationKenyaSTEP-TB
spellingShingle Lena Faust
Kawsar Abdi
Kristin Davis
Chen He
Caitlin Mehrotra
Emilie Stibolt
The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
Journal of Epidemiology and Global Health
Pediatric tuberculosis
fixed-dose combinations
impact evaluation
Kenya
STEP-TB
title The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
title_full The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
title_fullStr The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
title_full_unstemmed The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
title_short The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
title_sort roll out of child friendly fixed dose combination tb formulations in high tb burden countries a case study of step tb
topic Pediatric tuberculosis
fixed-dose combinations
impact evaluation
Kenya
STEP-TB
url https://www.atlantis-press.com/article/125917033/view
work_keys_str_mv AT lenafaust therolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT kawsarabdi therolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT kristindavis therolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT chenhe therolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT caitlinmehrotra therolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT emiliestibolt therolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT lenafaust rolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT kawsarabdi rolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT kristindavis rolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT chenhe rolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT caitlinmehrotra rolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb
AT emiliestibolt rolloutofchildfriendlyfixeddosecombinationtbformulationsinhightbburdencountriesacasestudyofsteptb